Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP versus triamcinolone injection for lumbar facet joint low back pain
IRCT20180804040685N6Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jan 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of platelet-rich plasma, triamcinolone and lidocaine in Lumbar facet syndrome (LFS) (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Pain intensity, Functional disability and 1 more. Started Jan 2026; status: completed.
02
Drugs
platelet-rich plasmatriamcinolonelidocaine
03
Conditions
Lumbar facet syndrome (LFS)
Beyond the preview
Go deeper on IRCT20180804040685N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180804040685N6.